Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01678404
Brief Title: 131I-rituximab for Relapsed or Refractory Marginal Zone B-cell Lymphoma

First Submitted : September 4, 2012
First Submitted that Met QC Criteria : September 4, 2012
First Posted : September 5, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : September 4, 2012
Last Update Posted : September 5, 2012 (Estimate)